FDA warning letters to peptide sellers, 2020
1 letter dated 2020 is on record for storefronts in the registry. Each row gives the date printed on the letter, the recipient as the record gives it, the agency's own page and the storefront's status on the day the file was last checked. Other years: 2021, 2024, 2025, 2026 · all years.
| Letter date | Recipient, as the record gives it | Products named | Storefront at last check | Letter | Pages |
|---|---|---|---|---|---|
| Paradigm PeptidesParadigm R.E. LLC | one product | Closed | fda.gov ↗ | letter page · file – |
What the record says each letter concerned
From the letter pages- Paradigm Peptides: letter dated 2020-12-07The record says the letter concerned one product named in the letter, marketed with COVID-19 claims and described by the agency as an unapproved new drug and misbranded.–
Reader questions
Answered from the fileWhich peptide sellers on file received an FDA warning letter in 2020?
Paradigm Peptides, letter dated 2020-12-07, addressed to Paradigm R.E. LLC. The list covers storefronts the desk keeps a file on, not every recipient in the agency's database.
Are the 2020 recipients still trading?
Paradigm Peptides: closed at the check on 2026-10-19.
Products are described only as GLP-class products or products named in the letter; the agency's own wording is on fda.gov. The tracker lists every year; the watchlist carries closures alongside the letters. Every storefront listed sells material labeled for laboratory research use only.